Transcript
Page 1: Risk for all vascular events across HDL-c quartiles,  with or without lipid-lowering therapy

Risk for all vascular events across HDL-c quartiles, with or without lipid-lowering therapy

HR

2

1

0,5

1 2 3 4

No lipid-lowering medicationLipid-lowering medication

Van de Woestijne et al., JACC 2013

Page 2: Risk for all vascular events across HDL-c quartiles,  with or without lipid-lowering therapy

Risk for all vascular events across HDL-c quartiles, with/without intensive lipid-lowering therapy

1 2 3 4

HR

0,5

2

1

No intensive lipid-lowering therapyIntensive lipid-lowering therapy

Van de Woestijne et al., JACC 2013


Recommended